SALES ALERT: Unlock 10-40% Off on All Cell Products!

Human Peripheral Blood CD14+ Monocytes (Positive Selection)

SKU: 10HU-008

Human Peripheral Blood CD14+ Monocytes (Positive Selection)

SKU: 10HU-008
Pricing Starting at

Starting at: $865.00

Available Options

SKUPackage SizePriceQuantityAdd to Cart
10HU-008-10MCryopreserved, 10 million cells/vialStarting at: $865.00
10HU-008-40MCryopreserved, 40 million cells/vialStarting at: $1,584.00

Associated Products


Product Description

Monocytes are innate blood cells that maintain vascular homeostasis and are early responders to pathogens in acute infections [1, 2]. Monocytes constitute 10~30% of peripheral blood mononuclear cells in the human body. They play multiple roles in immune function including replenishing resident macrophages under normal states. And in response to inflammation signals, monocytes can move quickly (approx. 8–12 hours) to sites of infection in the tissues and divide/differentiate into macrophages and dendritic cells to elicit an immune response [3]. CD14 is an important surface marker for monocytes.

iXCells Biotechnologies offers CD14+ monocytes isolated from normal human peripheral blood mononuclear cells (PBMCs) using positive immunomagnetic selection. > 90% of the cells are CD14+ as showed by flow cytometric analysis (Figure 1 A). And >53% of monocytes are capable to differentiate into mature dendritic cell (Fig 1B, C).

CD14+ monocytes

Figure 1. Human Peripheral Blood CD14+ Monocytes (Positive Selection). (A) >90% of purified cells are CD14 positive. (B, C) Flow cytometric analysis of monocytes dendritic cell differentiation, showed >53% of cells are CD83 positive and >77% cells are CD1a positive.

Product Details

Tissue Normal human peripheral blood
Package Size 1.0×107 cells/vial, 4.0×107 cells/vial
Purity >90%
Passage Number P0
Shipped Cryopreserved
Storage Liquid nitrogen
Growth Properties Suspension
Media Blood Cell Culture Medium (Cat# MD-0007)



[1] Martin Guilliams, Alexander Mildner, and Simon Yona. (2018) “Developmental and Functional Heterogeneity of Monocytes”. Immunity, 49: 595-613.

[2] Prakash Babu Narasimhan, Paola Marcovecchio, Anouk A.J. Hamers, and Catherine C. Hedrick. (2019) “Nonclassical Monocytes in Health and Disease”. Annual Reviews of Immunology, 37: 439-456.

[3] Ziegler-Heitbrock, L (2007). “The CD14+ CD16+ Blood Monocytes: their Role in Infection and Inflammation, Review”. J Leukocyte Biology 81 (3): 584–92.


Download Datasheet

Manuals & Protocols

  • Zhao, Y., Lee, C. K., Lin, C., Gassen, R. B., Xu, X., Huang, Z., . . . Hui, E. (2019). Pd-l1:cd80 cis-heterodimer triggers the co-stimulatory receptor cd28 while repressing the inhibitory pd-1 and ctla-4 pathways. Immunity, 51(6). doi:10.1016/j.immuni.2019.11.003 -- Learn More

  • Cho, H., Seo, Y., Loke, K. M., Kim, S., Oh, S., Kim, J., . . . Williams, D. R. (2018). Cancer-Stimulated cafs Enhance MONOCYTE differentiation AND Protumoral TAM activation via IL6 AND GM-CSF SECRETION. Clinical Cancer Research, 24(21), 5407-5421. doi:10.1158/1078-0432.ccr-18-0125 -- Learn More